Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Talazoparib and Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer

NCT04170946 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04170946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04170946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Talazoparib and Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Recruiting
Start date
October 5, 2020
Completion date
September 30, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, small-cell lung cancer